LONDON, June 28, 2018 /CNW/ - SSRN, Elsevier's world
leading preprint server and early stage research platform, has
today announced the launch of 'Preprints with The Lancet' -
a new preprint series for sharing early stage health and medical
research.
(Logo:
https://mma.prnewswire.com/media/712610/Preprints_with_The_Lancet_Logo.jpg
)
The collaboration brings together SSRN with The Lancet as
part of a six-month pilot to assess whether the health and medical
community are ready for this form of early research sharing.
Preprints are research papers that are at the submission stage
or can be described as on-going research. By sharing online,
authors widen the opportunity for receiving comments on their work
by other researchers with the goal of an improved final
peer-reviewed publication and for exchange of research areas with
the future potential for collaboration. Preprints are primarily
intended for research use; they have not been through the important
steps of peer review and experienced editorial scrutiny and
guidance that is part of the publishing process. All papers on
'Preprints with The Lancet' will be free to upload
and download.
Dr. Richard Horton,
Editor-In-Chief of The Lancet, said: "Preprints have a long
history in physics, mathematics, and, more recently, social
sciences and biological fields, but medicine and health have been
lagging behind. Our preprint pilot will be a first attempt to
establish whether there is an appetite in the medical research
community for obtaining feedback on ongoing or submitted research
in the form of preprints, and whether such postings are a useful
step in the research and publishing process."
Authors of all research papers submitted to any Lancet
family journal, will be asked at submission whether they would like
their paper to be posted - as a preprint, an opt-in that all
co-authors must agree to. Authors can also submit their papers
through SSRN directly.
Submitted papers will be subject to SSRN's usual checks to
ensure that the paper is part of the scholarly discourse, in a
subject area covered by one or more of SSRN's networks. A
Lancet editor will then check the paper and ensure the
authors have provided a statement about the funding of the study; a
summarized declaration of interests for all authors; a statement on
ethics approval or why the research was exempted; and if the
research is a randomized trial, confirmation that it has been
prospectively registered along with the trial registration number.
Once a final version of a preprint paper is peer-reviewed and
published and becomes part of the scientific evidence as the
version of record, authors are encouraged to link to the preprint
of the published paper.
Gregg Gordon, Managing Director
of SSRN, added: "It's fantastic The Lancet has decided to
embrace preprints and launch this new series. We have over 20
years' experience helping researchers from across the world, and
from all scientific disciplines, collaborate and share their early
stage research. With the new Sneak Peek series from Cell Press
recently launched on SSRN, we have two of the world's leading
journals from Elsevier working in partnership with us."
Note for editors
Interviews with Gregg Gordon,
Managing Director of SSRN, are available on request.
For more information about Preprints with The Lancet
please see:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31125-5/fulltext
and https://www.thelancet.com/preprints.
About SSRN
SSRN is a worldwide collaborative of over 350,000 authors and
more than 2.2 million users that is devoted to the rapid
worldwide dissemination fof research. Founded in 1994, it is now
composed of a number of specialized research networks. Each of
SSRN's networks encourages the early distribution of research
results by reviewing and distributing submitted abstracts and full
text papers from scholars around the world. SSRN encourages readers
to communicate directly with other subscribers and authors
concerning their own and other's research. Through email abstract
eJournals, SSRN currently reaches over 400,000 people in
approximately 140 different countries.
About Elsevier
Elsevier is a global information analytics business that helps
institutions and professionals advance healthcare, open science and
improve performance for the benefit of humanity. Elsevier provides
digital solutions and tools in the areas of strategic research
management, R&D performance, clinical decision support and
professional education, including ScienceDirect, Scopus, SciVal,
ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized
journals, including The Lancet and Cell, 38,000
e-book titles and many iconic reference works, including
Gray's Anatomy. Elsevier is part of RELX
Group, a global provider of information and analytics for
professionals and business customers across industries.
http://www.elsevier.com
SOURCE Elsevier